NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Aptargroup (ATR) was upgraded at JP Morgan to overweight from neutral. $61 price target. Stock reaction looks overdone, JP Morgan said.
Avago (AVGO) was downgraded at DA Davidson from buy to neutral. $38 price target. Company will likely see lower near-term margins, DA Davidson said.Strategic Hotels & Resorts (BEE) was upgraded at JMP Securities to market outperform from market perform. $7 price target. Valuation call, JMP said. Berry Petroleum (BRY) downgraded at Sterne Agee to neutral. Stock looks like a potential value trap, Sterne Agee said. Cardtronics (CATM) was upgraded at Compass Point from neutral to buy. $30 price target. Recent pullback has created a buying opportunity, Compass Point said. Dupont (DD - Get Report) was downgraded at Piper Jaffray from overweight to neutral. $51 price target. Estimates also cut, given lower TiO2 expectations, Piper Jaffray said. Dolby Laboratories (DLB) was downgraded at JMP Securities to market underperform from market perform. $26 price target. Skepticism company can achieve consensus expectations, JMP said. Fortress Investment Group (FIG - Get Report) was upgraded at Oppenheimer to outperform from perform. $7.50 price target. AUM is growing and the debt has gone, Oppenheimer said. Fortress was upgraded at Oppenheimer from perform to outperform. $7.50 price target. Assets under management have grown and the company trades at a discount to its fundamentals, Oppenheimer said. Guidewire (GWRE) was initiated with a buy rating at UBS. $36 price target. Visible track record of success, UBS said. Huntsman Corp. (HUN) was upgraded at Piper Jaffray to overweight from neutral. $21 price target. Polyurethanes are just getting started, Piper Jaffray said. Microstrategy (MSTR) was upgraded at Drexel Hamilton to hold. $90 price target. Consensus expectations appear too pessimistic, Drexel Hamilton said. OneBeacon Insurance (OB) was upgraded to buy at TheStreet Ratings. Perrigo (PRGO) was upgraded at Barrington from market perform to outperform. $142 price target. Company can continue to leverage its competitive advantages, Barrington said. Rowan (RDC) was downgraded at Dahlman Rose from buy to hold. International jackup utilization has likely peaked, Dahlman Rose said.